MARKET

HAE

HAE

Haemonetics Corp Mass
NYSE
122.36
+4.15
+3.51%
After Hours: 122.36 0 0.00% 19:30 11/10 EST
OPEN
117.90
PREV CLOSE
118.21
HIGH
123.08
LOW
116.68
VOLUME
797.95K
TURNOVER
--
52 WEEK HIGH
132.00
52 WEEK LOW
51.00
MARKET CAP
5.57B
P/E (TTM)
54.74
1D
5D
1M
3M
1Y
5Y
1D
Analysts Offer Insights on Healthcare Companies: Revolution Medicines (RVMD), Enovis (ENOV) and Haemonetics (HAE)
TipRanks · 22h ago
Weekly Report: what happened at HAE last week (1102-1106)?
Weekly Report · 2d ago
Will Raised Revenue Guidance Change Haemonetics Stock Narrative
Simply Wall St · 3d ago
Bank of America Securities Reaffirms Their Buy Rating on Haemonetics (HAE)
TipRanks · 4d ago
Haemonetics Is Maintained at Buy by Citigroup
Dow Jones · 4d ago
Haemonetics Price Target Raised to $149.00/Share From $123.00 by Citigroup
Dow Jones · 4d ago
Citigroup Maintains Buy on Haemonetics, Raises Price Target to $149
Benzinga · 4d ago
Haemonetics Price Target Raised to $145.00/Share From $140.00 by Barrington Research
Dow Jones · 4d ago
More
About HAE
Haemonetics Corporation is a medical technology company. Its solutions address critical medical needs, which includes a suite of hospital technologies designed to advance standards of care and help enhance outcomes for patients; end-to-end plasma collection technologies to optimize operations for plasma centers, and products to enable blood centers to collect in-demand blood components. Its Plasma segment includes plasma collection devices and disposables, donor management software and supporting software solutions. Its Blood Center segment manufactures and provides customers with its full line of apheresis solutions for automated blood collection. Its Hospital segment consists of Interventional Technologies, which includes Vascular Closure, Sensor Guided Technologies and Esophageal Protection products, and Blood Management Technologies (Hemostasis Management, Cell Salvage and Transfusion Management products). It also offers solutions for structural heart and endovascular procedures.

Webull offers Haemonetics Corp stock information, including NYSE: HAE real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, HAE stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading HAE stock methods without spending real money on the virtual paper trading platform.